R Squared Ltd Purchases New Stake in Encompass Health Co. (NYSE:EHC)

R Squared Ltd acquired a new position in Encompass Health Co. (NYSE:EHC) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 3,220 shares of the company’s stock, valued at approximately $297,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB raised its stake in Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after acquiring an additional 137 shares during the period. UMB Bank n.a. lifted its stake in shares of Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after buying an additional 252 shares in the last quarter. V Square Quantitative Management LLC boosted its holdings in Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after buying an additional 140 shares during the period. Avior Wealth Management LLC purchased a new position in Encompass Health in the 3rd quarter valued at approximately $40,000. Finally, Tompkins Financial Corp bought a new stake in Encompass Health during the 4th quarter valued at $46,000. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Stock Up 0.4 %

Shares of Encompass Health stock opened at $96.71 on Wednesday. Encompass Health Co. has a twelve month low of $70.74 and a twelve month high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The company’s 50 day moving average is $96.63 and its 200 day moving average is $94.57. The company has a market cap of $9.74 billion, a price-to-earnings ratio of 23.36, a price-to-earnings-growth ratio of 1.13 and a beta of 0.89.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business’s quarterly revenue was up 11.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.86 EPS. Research analysts anticipate that Encompass Health Co. will post 4.29 EPS for the current year.

Analysts Set New Price Targets

EHC has been the topic of several analyst reports. Royal Bank of Canada upped their price target on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Barclays increased their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. KeyCorp upped their price target on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Finally, Truist Financial reissued a “buy” rating and set a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Nine analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $107.11.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.